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Abstract 
 
After the structure originally proposed for nitraraine was shown to be incorrect by total synthesis, the 
alternative structure 5 was recently suggested for the alkaloid on biosynthetic grounds and by 
comparison with the 1H NMR data of tangutorine. The unambiguous synthesis of 5 is reported from 
tryptophanol and ketodiester 6, via oxazoloquinolone lactam 7. However, the melting point and 1H 
NMR data of 5 did not match those reported for the natural product. 
 
Nitraraine1 is an indole alkaloid isolated in 1985 from Nitraria schoberi L., collected in Kyzyl-Kum 
(Uzbekistan). On the basis of its mass-spectrometric fragmentation, spectroscopic UV, IR and 1H NMR 
data, chemical transformations and correlations, and degradation studies, the yohimbane-type structure 1 
was assigned to nitraraine (Figure 1). Catalytic hydrogenation of nitraraine afforded dihydronitraraine 
(assigned as 2), which had also been isolated from the same plant.2 Some years later, two new alkaloids, 
O-acetylnitraraine3 and nitraraidine,4 were also isolated from Nitraria species, and their structures were 
assigned as 3 and 4, respectively, mainly by chemical correlations with nitraraine and dihydronitraraine.  
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Figure 1. Structures proposed for nitraraine, dihydronitraraine, O-acetylnitraraine, and nitraraidine. 
 
A pentacyclic alcohol with the structure 1 had previously been prepared5 by LiAlH4 reduction of apo-
α-yohimbine. However, the data reported for this alcohol 1 (obtained as the hydrochloride) did not 
allow the proposed structure for nitraraine (isolated as the base) to be corroborated. 
Later on, three different syntheses of pentacyclic alcohol 1, either in enantiopure form6,7 or as a 
racemate,8 were reported. The melting point and 1H NMR data of 1 were significantly different from 
those reported for nitraraine. Similarly, the melting point of synthetic 2 differed6 from that of the 
alkaloid dihydronitraraine.2 Consequently, a reasonable doubt arose about the correct structure of the 
alkaloids of the nitraraine family. 
In 2011, Poupon et al. published9 an excellent and comprehensive article that provides a detailed 
analysis of the data available for nitraraine and the above-mentioned nitraraine-related alkaloids, 
suggesting pentacyclic alcohol 5, a structural isomer of 1, as a possible structure for nitraraine. The 
proposal was based on biosynthetic considerations10 and a comparison of the physical and spectroscopic 
data reported for these alkaloids with those of tangutorine11 and its O-acetyl and dihydro derivatives 
(Figure 2).  
 
Figure 2. Structure of tangutorine and putative structure of nitraraine. 
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Both nitraraine and tangutorine are alkaloids isolated from Nitraria species (Nitraria schoberi and 
Nitraria tangutorum, respectively), which belong to the Nitrariaceae family, whereas yohimbine-type 
alkaloids have a monoterpenoid origin and are found in plants of the Rubiaceae, Loganiaceae and 
Apocinaceae families. Moreover, the specific rotation reported for both alkaloids is zero, which could be 
attributed to similar biosynthetic pathways that do not involve the monoterpene secologanin. On the 
other hand, nitraraine, tangutorine, and their O-acetyl derivatives each have an olefinic proton that 
resonates at a very similar chemical shift in their 1H NMR spectra. Further, the melting point of these 
two alkaloids differs by only a few degrees Celsius. Another point of interest is that treatment of 
dihydronitraraine with p-TsCl provides the alkaloid nitraraidine, which is an N-quaternary hexacyclic 
salt, thus pointing to a cis D/E ring junction. Taking into account all the above, Poupon proposed the 
tangutorine diastereoisomer 5 as a plausible structure for nitraraine. 
In this communication we report the enantioselective total synthesis of 5. In the context of our studies 
on the use of tryptophanol-derived lactams as enantiomeric scaffolds for the synthesis of indole 
alkaloids,12 we visualized a synthetic route to this alcohol. Key steps to assemble the required 
pentacyclic skeleton would be a stereoselective cyclocondensation of (S)-tryptophanol with an 
appropriately substituted 6-oxocyclohexenepropionate derivative 6 and a Bischler−Napieralski 
cyclization of the resulting oxazoloquinolone lactam 713 (Scheme 1). The synthesis would also require 
the subsequent removal of the hydroxymethyl substituent coming from tryptophanol and the reduction 
of the ester function. 
 
 
 
 
 
 
 4
Scheme 1. Synthetic strategy 
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The required δ-keto ester 6 was prepared in 56% overall yield from ethyl 4-
oxocyclohexanecarboxylate 8, via keto sulfoxide 9, as outlined in Scheme 2.  
 
Scheme 2. Preparation of the starting δ-keto ester 6 
 
 
The cyclocondensation reaction of (S)-tryptophanol with δ-keto ester 6 stereoselectively gave 
tricyclic lactam 7 in 71% yield.14 Starting from 7, the closure of the central C ring was satisfactorily 
accomplished under classical Bischler−Napieralski reaction conditions. Without purification, treatment 
of the resulting hexacyclic derivative with LiAlH4 brought about both the reductive opening of the 
oxazolidine ring to stereoselectively give the required cis-decahydroquinoline ring junction and the 
reduction of the ester function, leading to the pentacyclic diol derivative 10 in 60% overall yield 
(Scheme 3). In contrast, a similar sequence from 7’ led to the indoloquinolizidine derivative 11, arising 
from an initial α-amidoalkylation reaction on the indole ring15 (Scheme 4). 
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Scheme 3. Synthesis of 5, the Putative Structure of Nitraraine 
 
Scheme 4. Cyclization of lactam 7’ 
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The next stage of the synthesis was the removal of the hydroxymethyl substituent coming from 
tryptophanol, which required the selective protection of the allylic hydroxy group, but unfortunately the 
insolubility of diol 10 precluded its manipulation. For this reason, the indole nitrogen of 7 was protected 
as a p-methoxybenzyl derivative, and the resulting lactam 12 was converted to 13 in 68% overall yield 
following the above Bischler−Napieralski cyclization−LiAlH4 reduction sequence. 
Once the allylic hydroxyl group was selectively protected with the bulky tert-butyldiphenylsilyl 
group, the removal of the hydroxymethyl substituent of 14 was performed in four steps: oxidation to 
aldehyde 15 using tetrapropylammonium perruthenate in the presence of N-methylmorpholine N-oxide 
as the co-oxidant (TPAP/NMO),16 subsequent dehydration of the corresponding oxime 16 with Burgess 
reagent, and reductive decyanation of the resulting α-amino nitrile.  
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Finally, deprotection of the indole nitrogen of pentacycle 17 using TFA in the presence of PhSH as a 
carbocation scavenger, followed by desilylation of the alcohol function gave the target pentacyclic 
alcohol 5. 
Our synthetic product 5 showed mass-spectral peaks with the same m/z as natural nitraraine.1 
However, the melting point (241-242 ºC) of 5 and the chemical shift of the olefinic proton in its 1H 
NMR spectrum (δ 5.86 in CF3CO2D) were different from those described for the alkaloid (mp 280-281 
ºC; δ 5.22 in CF3CO2H17) (Figure 3). 
 
 
Figure 3. Melting point and 1H NMR data of nitraraine and compound 5. 
 
The above data made evident that the real structure of nitraraine and related alkaloids remains an 
unsolved question and that further synthetic efforts are needed to reach a definitive conclusion. 
 
 
Experimental Section 
Ethyl 4-Oxo-3-(phenylsulfonyl)cyclohexanecarboxylate (9): First step: LDA (4.41 mL, 8.82 mmol of 
a 2 M solution in THF/heptane/ethylbenzene) was added at −78 °C to a solution of commercial ethyl 4-
oxocyclohexanecarboxylate (8; 1.5 g, 8.82 mmol) in dry THF (90 mL), and the solution was stirred for 
30 minutes. Then PhSSO2Ph (2.21 g, 8.82 mmol) in THF (10 mL) was added, and the resulting mixture 
was stirred at −78 °C for 40 minutes. The reaction was quenched with saturated aqueous NH4Cl (50 
mL), and the resulting mixture was extracted with EtOAc. The combined organic extracts were dried, 
filtered, and concentrated to afford ethyl 4-oxo-3-(phenylthio)cyclohexanecarboxylate, which was 
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used in the next step without purification: 1H NMR (400 MHz, CDCl3) δ 1.27 (t, J = 7.2 Hz, 3H), 1.93-
2.02 (m, 1H), 2.25-2.29 (m, 1H), 2.31-2.38 (m, 1H), 2.39-2.43 (m, 2H), 2.98-3.03 (m, 1H), 3.04-3.11 
(m, 1H), 3.89 (td, J = 4.4, 0.8 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 7.29 (d, J = 7.2 Hz, 2H), 7.40 (dd, J = 
8.8, 2.0 Hz, 2H), 7.56 (d, J = 6.8 Hz, 1H). Second step: A solution of m-CPBA (70%, 2.17 g, 8.82 
mmol) in CH2Cl2 (20 mL) was added at −78 °C to a solution of the above phenylthio derivative (2.46 g, 
8.82 mmol) in CH2Cl2 (180 mL). After 5 minutes, the reaction was quenched with the addition of 
saturated aqueous Na2S2O3. The resulting mixture was extracted with CH2Cl2, and the combined organic 
extracts were washed with saturated aqueous NaHCO3 and brine, dried, filtered, and concentrated. Flash 
chromatography of the residue (4:1 hexane−EtOAc) afforded the sulfonyl derivative 9 (2.38 g, 93% 
yield for the two steps) as a complex mixture of diastereoisomers. HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C15H19O4S 295.0999; Found 295.0999. 
Methyl 3-(Ethoxycarbonyl)-6-oxocyclohexenepropionate (6): A solution of DBU (374 mg, 2.45 
mmol) in DMF (5 mL) was added at −40 ºC, under inert atmosphere, to a solution of the above sulfonyl 
derivatives 9 (720 mg, 2.45 mmol) in DMF (15 mL), and the resulting mixture was stirred for 20 min. A 
solution of methyl acrylate (211 mg, 2.45 mmol) in DMF (5 mL) was then added to the mixture, and the 
reaction was allowed to reach 10 ºC over 1.5 h. The reaction was quenched with saturated aqueous 
NH4Cl (20 mL), and the resulting mixture was extracted with Et2O. The organic layer was dried and 
filtered, and the filtrate was stirred at room temperature for 20 h. After this time, the solvent was 
evaporated under reduced pressure. Flash chromatography of the residue (hexane to 9.5:0.5 
hexane−EtOAc) afforded oxoester 6 (375 mg, 60%): IR (film) ν (cm-1) 1678 (CO), 1736 (CO); 1H NMR 
(400 MHz, CDCl3, COSY, g-HSQC) δ 1.30 (t, J = 7.1 Hz, 3H, CH3), 2.12-2.23 (m, 1H, H-4’), 2.30-
2.41 (m, 2H, H-2, H-4’), 2.44-2.49 (m, 2H, H-3), 2.53-2.61 (m, 3H, H-2, H-5’), 3.36-3.42 (m, 1H, H-
3’), 3.66 (s, 3H, OCH3), 4.21 (q, J = 7.1 Hz, 2H, CH2CH3), 6.85 (d, J = 4.4 Hz, 1H, H-2’); 13C NMR 
(100.6 MHz, CDCl3) δ 14.1 (CH3), 25.4 (C-3), 25.7 (C-4’), 32.8 (C-5’), 36.6 (C-2), 42.0 (C-3’), 51.5 
(OCH3), 61.3 (CH2CH3), 132.6 (C-1’), 142.3 (C-2’), 171.8 (COO), 173.3 (COO), 197.8 (CO); HRMS 
(ESI-TOF) m/z: [M + H]+ Calcd for C13H19O5 255.1227; Found 255.1228. 
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Ethyl (3S,7aR,11aR)-3-(3-Indolylmethyl)-5-oxo-2,3,5,6,7,7a,10,11-octahydrooxazolo[2,3-
j]quinoline-9-carboxylate (7): Isobutyric acid (105 µL, 1.13 mmol) was added to a solution of 
tryptophanol (97 mg, 0.51 mmol) and oxoester 6 (100 mg, 0.39 mmol) in toluene (8 mL). The mixture 
was stirred at reflux for 24 h, with azeotropic elimination of water by a Dean-Stark system. The 
resulting mixture was cooled and concentrated under reduced pressure. The residue was dissolved in 
EtOAc and washed with saturated aqueous NaHCO3. The combined organic extracts were dried, 
filtered, and concentrated to give a foam. Crystallization from EtOAc gave lactam 7 (109 mg, 71%). 
Evaporation of the solvent afforded the (3S,7aS,11aS) diastereoisomer (7’; 19 mg, 17%). Lactam 7: 
[α]22D + 20.2 (c 1.0, CHCl3); IR (film) ν (cm-1) 1629 (NCO), 1714 (COO), 3303 (NH); 1H NMR (400 
MHz, CDCl3, COSY, g-HSQC) δ 1.28 (t, J = 7.5 Hz, 3H, CH3), 1.56-1.68 (m, 2H, H-7, H-11), 1.95 
(dm, J = 14.0 Hz, 1H, H-7), 2.05-2.10 (m, 1H, H-11), 2.25-2.30 (m, 1H, H-7a), 2.33-2.39 (m, 1H, H-
10), 2.43-2.52 (m, 2H, H-6, H-10), 2.63 (dd, J = 18.4, 6.4 Hz, 1H, H-6), 2.89 (dd, J = 14.0, 10.4 Hz, 
1H, CH2-ind), 3.62 (ddd, J = 14.0, 3.4, 0.8 Hz, 1H, CH2-ind), 3.81 (dd, J = 8.8, 8.0 Hz, 1H, H-2), 4.01 
(dd, J = 8.8, 8.0 Hz, 1H, H-2), 4.19 (q, J = 7.5 Hz, 2H, CH2CH3), 4.67 (dtd, J = 10.4, 8.0, 8.0, 3.4 Hz, 
1H, H-3), 6.84 (dd, J = 5.0, 2.0 Hz, 1H, H-8), 7.01 (d, J = 2.4 Hz, 1H, ArH), 7.12 (td, J = 8.0, 1.2 Hz, 
1H, ArH), 7.20 (td, J = 8.0, 1.2 Hz, 1H, ArH), 7.34 (d, J = 8.0 Hz, 1H, ArH), 7.89 (d, J = 8.0 Hz, 1H, 
ArH), 8.40 (s, 1H, NH ind); 13C NMR (100.6 MHz, CDCl3) δ 14.2 (CH3), 22.6 (C-10), 25.5 (C-7), 26.3 
(C-11), 30.2 (CH2-ind), 31.0 (C-6), 40.6 (C-7a), 56.2 (C-3), 60.6 (CH2CH3), 68.2 (C-2), 92.6 (C-11a), 
111.1 (CHAr), 111.6 (CAr), 119.2 (CHAr), 119.5 (CHAr), 122.0 (CHAr), 122.1 (CHAr), 127.5 (CAr), 
129.6 (C-9), 136.2 (CAr), 137.7 (C-8), 166.5 (CO2), 169.4 (CO); HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C23H27N2O4 395.1965; Found 395.1978. Anal. Calcd. for C23H26N2O4·1/2 H2O: C 68.47; H 
6.74, N 6.94. Found: C 68.42; H 6.60; N 6.59. Lactam 7’: [α]22D − 40.8 (c 0.8, CHCl3); IR (film) ν (cm-
1) 1628 (NCO), 1706 (COO), 3297 (NH); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.28 (t, J = 
7.2 Hz, 3H, CH3), 1.53-1.63 (m, 2H, H-7, H-11), 2.02 (dd, J = 14.0, 6.0 Hz, 1H, H-7), 2.11-2.20 (m, 
1H, H-11), 2.31-2.39 (m, 2H, H-7a, H-10), 2.48-2.51 (m, 3H, H-6, H-10), 2.76 (dd, J = 14.0, 9.6 Hz, 
1H, CH2-ind), 3.79 (dd, J = 14.0, 2.0 Hz, 1H, CH2-ind), 3.97 (m, 2H, H-2), 4.18 (q, J = 7.2 Hz, 2H, 
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CH2CH3), 4.42 (m, 1H, H-3), 6.90 (dd, J = 5.0, 2.4 Hz, 1H, H-8), 7.04 (d, J = 2.4 Hz, 1H, ArH), 7.13 
(td, J = 7.5, 1.2 Hz, 1H, ArH), 7.20 (td, J = 7.5, 1.2 Hz, 1H, ArH), 7.36 (d, J = 7.5 Hz, 1H, ArH), 7.80 
(d, J = 7.5 Hz, 1H, ArH), 8.07 (s, 1H, NH ind); 13C NMR (100.6 MHz, CDCl3) δ 14.2 (CH3), 22.8 (C-
10), 25.7 (C-7), 26.3 (C-11), 26.6 (CH2-ind), 30.1 (C-6), 39.8 (C-7a), 56.5 (C-3), 60.6 (CH2CH3), 67.4 
(C-2), 92.7 (C-11a), 111.0 (CHAr), 112.4 (CAr), 119.3 (CHAr), 119.6 (CHAr), 122.2 (CHAr), 122.3 
(CHAr), 127.7 (CAr), 129.2 (C-9), 136.1 (CAr), 138.8 (C-8), 166.6 (CO2), 168.1 (CO); HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C23H27N2O4 395.1965; Found 395.1971. 
(2aR,6aS,8S,14bS)-4,8-Bis(hydroxymethyl)-2,2a,5,6,6a,8,9,14b-octahydro-1H-benz[f]indolo[2,3-
a]quinolizine (10): POCl3 (1.12 mL, 12.16 mmol) was added to a solution of lactam 7 (600 mg, 1.52 
mmol) in toluene (20 mL), and the solution was stirred at 100 ºC for 1.5 h. The solvent was evaporated, 
and dry methanol (30 mL) was added to the residue. NaBH4 (173 mg, 4.57 mmol) was slowly added at 0 
ºC to the solution, and the mixture was stirred, allowing it to reach room temperature (about 1.5 h). The 
reaction was quenched by addition of saturated aqueous NaHCO3. The methanol was evaporated, and 
the aqueous solution was extracted with CH2Cl2. The combined organic extracts were dried, filtered, and 
concentrated. LiAlH4 (866 mg, 23 mmol) was added to a solution of the resulting residue in anhydrous 
THF (25 mL), and the mixture was stirred at reflux for 3 h. The reaction was quenched at 0 ºC with 
water (866 µL), and 10% aqueous NaOH (866 µL) and then water (2.5 mL) were added. The resulting 
suspension was dried with MgSO4, filtered, and concentrated. Flash chromatography of the resulting oil 
(9:1 CH2Cl2–MeOH) afforded pentacyclic compound 10 as a light yellow foam (308 mg, 60%): IR 
(film) ν (cm-1) 3402 (OH, NH); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.14 (qd, J = 12.8, 4.8 
Hz, 1H, H-6), 1.40 (qd, J = 13.2, 4.8 Hz, 1H, H-2), 1.67 (m, 2H, H-2, H-6), 1.78 (dd, J = 17.2, 4.0 Hz, 
1H, H-5), 1.91 (m, 1H, H-5), 2.12 (m, 1H, H-1), 2.35 (m, 2H, H-1, H-2a), 2.80 (dd, J = 8.8, 1.6 Hz, 2H, 
H-9), 3.27 (dq, J = 12.8, 2.4 Hz, 1H, H-6a), 3.51 (m, 1H, H-8), 3.82 (s, 2H, CH2OH), 3.86 (dd, J = 11.6, 
6.4 Hz, 1H, CH2OH), 4.04 (dd, J = 11.6, 7.6 Hz, 1H, CH2OH), 4.27 (brs, 1H, H-14b), 5.55 (d, J = 4.0 
Hz, 1H, H-3), 6.99 (td, J = 7.6, 0.8 Hz, 1H, ArH), 7.06 (td, J = 8.0, 1.2 Hz, 1H, ArH), 7.33 (d, J = 8.0 
Hz, 1H, ArH), 7.37 (d, J = 7.6 Hz, 1H, ArH); 13C NMR (100.6 MHz, CDCl3) δ 24.2 (C-6), 25.1 (C-2), 
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26.5 (C-9), 27.1 (C-1), 27.3 (C-5), 37.6 (C-2a), 53.8 (C-14b), 55.9 (C-6a), 62.9 (C-8), 64.3 (CH2OH), 
66.7 (CH2OH), 108.5 (CAr), 112.0 (CHAr), 118.3 (CHAr), 119.7 (CHAr), 121.7 (CHAr), 127.1 (C-3), 
128.9 (CAr), 137.5 and 137.8 (2CAr, C-4); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H27N2O2 
339.2067; Found 339.2064. 
(9S,4aS,15bR)-3,9-Bis(hydroxymethyl)-1,2,4a,5,6,7,9,10-octahydrobenz[i]indolo[2,3-a]quinolizine 
(11): Operating as in the above cyclization of lactam 7, from the minor isomer 7’ (180 mg, 0.35 mmol) 
in toluene (5.0 mL) and POCl3 (257 µL, 2.79 mmol), then NaBH4 (40 mg, 1.05 mmol) in anhydrous 
methanol (7.0 mL), and finally LiAlH4 (200 mg, 5.25 mmol) in THF (6 mL), compound 11 (77 mg, 
65%) was obtained after column chromatography (9:1 CH2Cl2–MeOH): IR (film) ν (cm-1) 3405 (OH, 
NH); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.40 (dm, J = 12.4 Hz, 1H, H-6), 1.51 (dt, J = 
14.4, 4.4 Hz, 1H, H-5), 1.58 (dm, J = 12.4 Hz, 1H, H-5), 1.60 (m, 1H, H-6), 1.79 (m, 1H, H-1), 2.01 
(dm, J = 16.0 Hz, 1H, H-2), 2.25 (dm, J = 16.0 Hz, 1H, H-2), 2.30 (ddd, J = 13.2, 4.4, 2.8 Hz, 1H, H-1), 
2.38 (td, J = 12.0, 2.4 Hz, 1H, H-7), 2.51 (dd, J = 15.6, 4.0 Hz, 1H, H-10), 2.63 (dd, J = 15.6, 10.4 Hz, 
1H, H-10), 2.73 (m, 1H, H-7), 2.84 (brs, 1H, H-4a), 3.64 (d, J = 5.2 Hz, 1H, CH2OH), 3.75-3.79 (m, 2H, 
H-9, CH2OH), 4.12 (s, 2H, CH2OH), 7.10 (td, J = 7.2, 0.8 Hz, 1H, ArH), 7.16 (td, J = 7.2, 0.8 Hz, 1H, 
ArH), 7.33 (d, J = 7.6 Hz, 1H, ArH), 7.46 (d, J = 7.6 Hz, 1H, ArH); 13C NMR (100.6 MHz, CDCl3) δ 
19.3 (C-10), 21.1 (C-6), 22.6 (C-2), 27.4 (C-5), 34.6 (C-1), 38.7 (C-4a, C-7), 54.0 (C-9), 56.5 (C-15b), 
61.2 (CH2OH), 66.5 (CH2OH), 107.1 (CAr), 110.9 (CHAr), 118.0 (CHAr), 119.5 (CHAr), 121.5 
(CHAr), 125.0 (C-4), 127.4 (CAr), 135.4 (CAr), 137.9 (CAr), 138.5 (C-3); HRMS (ESI-TOF) m/z: [M + 
H]+ Calcd for C21H27N2O2 339.2067; Found 339.2066. 
Ethyl (3S,7aR,11aR)-3-[1-(4-Methoxybenzyl)-3-indolylmethyl]-5-oxo-2,3,5,6,7,7a,10,11-
octahydrooxazolo[2,3-j]quinoline-9-carboxylate (12): Lactam 7 (195 mg, 0.49 mmol) was added at 0 
ºC under a nitrogen atmosphere to a suspension of NaH (60% dispersion in mineral oil, 18 mg, 0.74 
mmol) in dry DMF (5 mL), and the resulting mixture was stirred for 30 minutes. 4-Methoxybenzyl 
chloride (80 µl, 0.59 mmol) was added, and the stirring was continued at 0 ºC for 1 h. After 
neutralization with saturated aqueous NH4Cl, the mixture was extracted three times with Et2O. The 
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combined organic extracts were washed with brine, dried, filtered, and concentrated. Flash 
chromatography of the residue (4:1 hexane−EtOAc) provided lactam 12 (170 mg, 67%): IR (film) 
ν (cm-1) 1643 (NCO), 1707 (COO); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.28 (t, J = 6.8 Hz, 
3H, CH3), 1.53-1.57 (m, 2H, H-7, H-11), 1.84 (dd, J = 14.0, 5.6 Hz, 1H, H-11), 2.04-2.10 (m, 1H, H-7), 
2.25-2.29 (m, 1H, H-7a), 2.29-2.34 (m, 1H, H-10), 2.39 (m, 1H, H-10), 2.46 (ddd, J = 18.8, 11.6, 7.2 
Hz, 1H, H-6), 2.62 (dd, J = 18.8, 5.2 Hz, 1H, H-6), 2.93 (dd, J = 14.4, 4.0 Hz, 1H, CH2-ind), 3.56 (dd, J 
= 14.4, 3.2 Hz, 1H, CH2-ind), 3.77 (s, 3H, CH3O), 3.79 (t, J = 8.8 Hz, 1H, CH2O), 4.00 (t, J = 8.8 Hz, 
1H, CH2O), 4.18 (q, J = 6.8 Hz, 2H, CH2CH3), 4.64 (ddd, J = 11.2, 8.0, 3.2 Hz, 1H, H-3), 5.20 (s, 2H, 
NCH2), 6.83 (d, J = 8.4 Hz, 3H, H-8, ArH), 6.93 (s, 1H, H-2 ind), 7.06 (d, J = 8.4 Hz, 2H, ArH), 7.12 (t, 
J = 7.2 Hz, 1H, ArH), 7.19 (t, J = 7.2 Hz, 1H, ArH), 7.28 (d, J = 8.0 Hz, 1H, ArH), 7.78 (d, J = 8.0 Hz, 
1H, ArH); 13C NMR (100.6 MHz, CDCl3) δ 14.2 (CH3), 22.6 (C-10), 25.6 (C-7), 26.2 (C-11), 29.9 
(CH2-ind), 30.9 (C-6), 40.6 (C-7a), 49.3 (NCH2), 55.2 (CH3O), 56.3 (C-3), 60.5 (CH3CH2), 68.0 
(CH2O), 92.6 (C-11a), 109.6 (CHAr), 110.8 (CAr), 114.1 (CHAr), 119.3 (CHAr), 119.5 (CHAr), 121.9 
(CHAr), 126.0 (CHAr), 128.2 (CHAr), 129.4 (CAr), 129.6 (CAr), 130.0 (C-9), 136.5 (CAr), 137.7 (C-
8), 159.1 (CAr), 166.5 (CO2), 169.3 (CO); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C31H35N2O5 
515.2540; Found 515.2545. 
(2aR,6aS,8S,14bS)-4,8-Bis(hydroxymethyl)-14-(4-methoxybenzyl)-2,2a,5,6,6a,8,9,14b-octahydro-
1H-benz[f]indolo[2,3-a]quinolizine (13): Operating as in the preparation of compound 10, from lactam 
12 (2.04 g, 4.66 mmol) in toluene (58 mL) and POCl3 (3.4 mL, 37.3 mmol), then NaBH4 (540 mg, 14 
mmol) in anhydrous methanol (92 mL), and finally LiAlH4 (1.77 g, 46.6 mmol) in THF (90 mL), 
pentacyclic diol 13 (1.45 g, 68%) was obtained after purification by column chromatography (99:1 
CH2Cl2–MeOH): mp: 119-122 ºC; [α]22D − 34.0 (c 0.4, CHCl3); IR (film) ν (cm-1) 3428 (OH); 1H NMR 
(400 MHz, CDCl3, COSY, g-HSQC) δ 1.26-1.41 (m, 2H, H-2, H-6), 1.60-1.70 (m, 2H, H-2, H-6), 1.81 
(dd, J = 14.4, 3.2 Hz, 1H, H-5), 1.87-2.02 (m, 2H, H-1, H-5), 2.19-2.25 (m, 1H, H-1), 2.39 (m, 1H, H-
2a), 2.78-2.82 (m, 2H, H-9), 3.31 (ddd, J = 12.0, 5.2, 3.2 Hz, 1H, H-6a), 3.53 (tt, J = 8.8, 6.4 Hz, 1H, H-
8), 3.75 (s, 3H, CH3O), 3.75-3.81 (dd, J = 11.2, 5.2 Hz, 1H, CH2OH), 3.90 (s, 2H, CH2OH), 3.87-3.95 
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(dd, J = 12.0, 5.2 Hz, 1H, CH2OH), 4.22 (t, J = 5.2 Hz, 1H, H-14b), 5.25 (d, J = 17.2 Hz, 1H, NCH2), 
5.43 (d, J = 17.2 Hz, 1H, NCH2), 5.48 (d, J = 3.2 Hz, 1H, H-3), 6.78 (d, J = 8.4 Hz, 2H, ArH), 6.83 (d, J 
= 8.4 Hz, 2H, ArH), 7.11 (td, J = 7.2, 1.2 Hz, 1H, ArH), 7.15 (td, J = 6.8, 1.2 Hz, 1H, ArH), 7.23 (d, J = 
8.0 Hz, 1H, ArH), 7.47 (d, J = 6.8 Hz, 1H, ArH); 13C NMR (100.6 MHz, CDCl3) δ 24.8 (C-6), 25.0 (C-
2), 25.2 (C-9), 26.2 (C-5), 27.1 (C-1), 36.2 (C-2a), 47.5 (NCH2), 53.0 (C-6a), 54.5 (C-14b), 55.2 
(CH3O), 61.0 (C-8), 62.5 (CH2OH), 66.6 (CH2OH), 109.3 (CHAr), 110.0 (CAr), 114.2 (CHAr), 117.8 
(CHAr), 119.4 (CHAr), 121.5 (CHAr), 126.4 (C-3), 126.6 (CHAr), 126.9, 130.1 and 136.9 (C-4, 2CAr), 
137.9 (CAr), 158.7 (CAr); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C29H35N2O3 459.2642; Found 
459.2628. 
(2aR,6aS,8S,14bS)-4-[(tert-Butyldiphenylsilyloxy)methyl]-8-(hydroxymethyl)-14-(4-
methoxybenzyl)-2,2a,5,6,6a,8,9,14b-octahydro-1H-benz[f]indolo[2,3-a]quinolizine (14): Imidazole 
(32 mg, 0.48 mmol) and tert-butyldiphenylsilyl chloride (191 µl, 0.72 mmol) were added at 0 °C to a 
solution of diol 13 (220 mg, 0.48 mmol) in CH2Cl2 (25 mL). The solution was stirred for 15 minutes at 
this temperature. Then saturated aqueous NH4Cl was added, and the mixture was extracted with CH2Cl2. 
The combined organic extracts were dried, filtered, and concentrated. Flash chromatography (99:1 
CH2Cl2–MeOH) of the residue afforded alcohol 14 as a yellow foam (254 mg, 76%): IR (film) ν (cm-1) 
3428 (OH), 1109 (OSi); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.02 [s, 9H, C(CH3)3], 1.26-
1.37 (m, 2H, H-2, H-6), 1.60-1.66 (m, 2H, H-2, H-6), 1.80-1.83 (m, 2H, H-5), 1.93-2.04 (m, 1H, H-1), 
2.25-2.29 (m, 1H, H-1), 2.39 (m, 1H, H-2a), 2.79-2.82 (m, 2H, H-9), 3.31 (dm, J = 12.0 Hz, 1H, H-6a), 
3.53-3.57 (m, 1H, H-8), 3.73 (s, 3H, CH3O), 3.81 (dd, J = 10.8, 4.8 Hz, 1H, CH2OH), 3.94 (s, 2H, 
CH2OSi), 3.91-3.96 (m, 1H, CH2OH), 4.26 (m, 1H, H-14b), 5.27 (d, J = 17.6 Hz, 1H, NCH2), 5.45 (d, J 
= 17.6 Hz, 1H, NCH2), 5.48 (m, 1H, H-3), 6.79 (d, J = 8.4 Hz, 2H, ArH), 6.84 (d, J = 8.4 Hz, 2H, ArH), 
7.11 (td, J = 7.6, 1.2 Hz, 1H, ArH), 7.16 (td, J = 8.0, 1.2 Hz, 1H, ArH), 7.24 (d, J = 7.2 Hz, 1H, ArH), 
7.31-7.41 (m, 6H, ArH), 7.47 (d, J = 6.8 Hz, 1H, ArH), 7.60-7.64 (m, 4H, ArH); 13C NMR (100.6 MHz, 
CDCl3) δ 19.2 [C(CH3)3], 24.7 and 24.8 (C-6, C-2), 25.2 (C-9), 26.1 (C-5), 26.8 [C(CH3)3], 27.1 (C-1), 
36.3 (C-2a), 47.5 (NCH2), 53.0 (C-6a), 54.6 (C-14b), 55.2 (CH3O), 61.3 (C-8), 62.4 (CH2OH), 67.1 
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(CH2OSi), 109.3 (CHAr), 110.0 (CAr), 114.2 (CHAr), 117.8 (CHAr), 119.4 (CHAr), 121.5 (CHAr), 
125.1 (C-3), 126.6 (CHAr), 126.9 (CAr), 130.1 (CAr), 133.7 (CAr), 133.7 (CAr), 136.2 (C-4, CAr), 
137.9 (CAr), 158.7 (CAr); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C45H53N2O3Si 697.3820; Found 
697.3807. 
(2aR,6aS,8S,14bS)-4-[(tert-Butyldiphenylsilyloxy)methyl]-8-formyl-14-(4-methoxybenzyl)-
2,2a,5,6,6a,8,9,14b-octahydro-1H-benz[f]indolo[2,3-a]quinolizine (15): 4Å Powdered sieves (376 
mg) and NMO (115 mg, 0.96 mmol) were added at room temperature under an inert atmosphere to a 
solution of alcohol 14 (190 mg, 0.27 mmol) in CH3CN (6 mL). Tetrapropylammonium perruthenate (19 
mg, 0.054 mmol) was then added in one portion, and the resulting mixture was stirred at room 
temperature for 30 minutes. The solvent was evaporated, and the dark residue was dissolved in CH2Cl2. 
The solution was filtered through a short pad of silica using CH2Cl2 as the eluent. The filtrate was 
concentrated to give aldehyde 15 (95 mg, 50%), which was used in the next step without purification: IR 
(film) ν (cm-1) 1656 (CHO), 1110 (OSi); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.03 [s, 9H, 
C(CH3)3], 1.49 (qd, J = 12.8, 4.0 Hz, 1H, H-1), 1.65-1.79 (m, 3H, H-2, H-6), 1.83 (dm, J = 12.8 Hz, 1H, 
H-1), 1.93-1.96 (m, 2H, H-5), 2.14 (m, 1H, H-6), 2.47 (s, 1H, H-2a), 3.04 (ddd, J = 15.2, 5.6, 2.0 Hz, 
1H, H-9), 3.23 (d, J = 15.2 Hz, 1H, H-9), 3.73 (m, 1H, H-6a), 3.74 (s, 3H, CH3O), 3.97 (m, 1H, H-8), 
4.08 (s, 2H, CH2OSi), 4.18 (d, J = 10.8 Hz, 1H, H-14b), 5.14 (d, J = 16.8 Hz, 1H, NCH2), 5.23 (d, J = 
16.8 Hz, 1H, NCH2), 5.27 (s, 1H, H-3), 6.78 (d, J = 8.8 Hz, 2H, ArH), 6.87 (d, J = 8.8 Hz, 2H, ArH), 
7.03 (m, 1H, ArH), 7.06-7.09 (m, 2H, ArH), 7.24-7.34 (m, 6H, ArH), 7.51 (m, 1H, ArH), 7.64-7.68 (m, 
4H, ArH), 9.66 (s, 1H, CHO); 13C NMR (100.6 MHz, CDCl3) δ 19.2 [C(CH3)3], 21.3 (C-5), 23.3 (C-9), 
26.8 [C(CH3)3, C-6], 29.4 (C-1), 30.6 (C-2), 35.9 (C-2a), 47.2 (NCH2), 55.2 (CH3O), 55.3 (C-6a), 55.6 
(C-14b), 59.8 (C-8), 67.6 (CH2OSi), 107.1 (CAr), 110.0 (CHAr), 114.1 (CHAr), 117.9 (CHAr), 119.4 
(CHAr), 121.4 (CHAr), 124.3 (C-3), 126.7 (CAr), 127.0 (CHAr), 127.5 (CHAr), 129.5 (CHAr), 135.4 
(CAr), 135.5 (CAr), 137.1 (CAr), 137.8 (C-4), 137.9 (CAr), 158.7 (CAr), 205.6 (CHO); HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C45H51N2O3Si 695.3663; Found 695.3636. 
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(2aR,6aS,8S,14bS)-4-[(tert-Butyldiphenylsilyloxy)methyl]-8-[(hydroxyimino)methyl]-14-(4-
methoxybenzyl)-2,2a,5,6,6a,8,9,14b-octahydro-1H-benz[f]indolo[2,3-a]quinolizine (16): 
NH2OH·HCl (42 mg, 0.59 mmol) was added to a solution of aldehyde 15 (75 mg, 0.11 mmol) in 
pyridine (250 µL) and ethanol (250 µL). The mixture was heated at reflux for 2 h, and then the solvent 
was removed under reduced pressure. 0.2 N Aqueous H2SO4 (2 mL) was added, and the mixture was 
stirred for 10 minutes and extracted with EtOAc. The organic extracts were washed with 2 N aqueous 
NaOH, dried, filtered, and concentrated to afford oximes 16 (44 mg, 56%): Major isomer: IR (film) 
ν (cm-1) 1110 (OSi); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.02 [s, 9H, C(CH3)3], 1.48-1.52 
(m, 2H, H-2, H-5), 1.64-1.67 (m, 3H, H-1, H-2, H-6), 1.91 (m, 1H, H-5), 2.00 (m, 1H, H-1), 2.32 (d, J = 
14.0 Hz, 1H, H-6), 2.46 (m, 1H, H-2a), 2.79 (d, J = 15.2 Hz, 1H, H-9), 3.06 (brs, 1H, H-6a), 3.16 (ddd, J 
= 15.2, 5.2, 2.0 Hz, 1H, H-9), 3.68 (d, J = 10.4 Hz, 1H, H-14b), 3.75 (s, 3H, CH3O), 4.08 (s, 2H, 
CH2OSi), 4.15 (m, 1H, H-8), 5.17 (d, J = 17.2 Hz, 1H, NCH2), 5.29 (m, 1H, H-3), 5.30 (d, J = 17.2 Hz, 
1H, NCH2), 6.80 (d, J = 8.4 Hz, 2H, ArH), 6.88 (d, J = 8.4 Hz, 2H, ArH), 7.09 (d, J = 4.8 Hz, 2H, ArH), 
7.28-7.36 (m, 7H, ArH), 7.33 (m, 1H, CHNOH), 7.48 (m, 1H, ArH), 7.64-7.68 (m, 4H, ArH); 13C NMR 
(100.6 MHz, CDCl3) δ 19.3 [C(CH3)3], 21.2 (C-2), 26.6 (C-9), 26.8 [C(CH3)3, C-6], 29.7 (C-1), 29.7 (C-
5), 36.0 (C-2a), 47.4 (NCH2), 50.0 (C-8), 55.2 (CH3O), 55.4 (C-6a), 55.6 (C-14b), 67.5 (CH2OSi), 107.0 
(CAr), 109.8 (CHAr), 114.1 (CHAr), 118.0 (CHAr), 119.3 (CHAr), 121.4 (CHAr), 124.2 (C-3), 127.0 
(CHAr), 127.2 (CHAr), 127.5 (CHAr), 127.6 (CHAr), 129.5 (CHAr), 129.7 (CAr), 133.9 (CAr), 134.0 
(CAr), 135.4 (CHAr), 135.5 (CHAr), 136.7 (CAr), 137.5 (C-4), 138.3 (CAr), 151.2 (CHNOH), 158.8 
(CAr); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C45H52N3O3Si 710.3772; Found 710.3762. Minor 
isomer: 1H NMR (400 MHz, CDCl3, COSY, g-HSQC, selected resonances) δ 1.02 [s, 9H, C(CH3)3], 
2.35 (dm, J = 14.0 Hz, 1H, H-6), 2.43 (m, 1H, H-2a), 2.89 (d, J = 15.2 Hz, 1H, H-9), 2.96 (brs, 1H, H-
6a), 3.10 (m, 1H, H-9), 3.65 (d, J = 10.4 Hz, 1H, H-14b), 3.75 (s, 3H, CH3O), 4.08 (s, 2H, CH2OSi), 
4.82 (m, 1H, H-8), 5.18 (d, J = 17.2 Hz, 1H, NCH2), 5.27 (m, 1H, H-3), 5.33 (d, J = 17.2 Hz, 1H, 
NCH2), 6.76 (m, 1H, CHNOH), 6.78 (d, J = 8.4 Hz, 2H, ArH), 6.87 (d, J = 8.4 Hz, 2H, ArH), 7.09 (s, 
1H, ArH), 7.28-7.36 (m, 7H, ArH), 7.48 (m, 1H, ArH), 7.64-7.68 (m, 4H, ArH). 
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(2aR,6aS,14bS)-4-[(tert-Butyldiphenylsilyloxy)methyl]-14-(4-methoxybenzyl)-2,2a,5,6,6a,8,9,14b-
octahydro-1H-benz[f]indolo[2,3-a]quinolizine (17): First step: Burgess reagent was added in three 
portions (3 x 30 mg) to a solution of oximes 16 (88 mg, 0.12 mmol) in CH2Cl2 (1.25 mL) over a period 
of 2 hours. The resulting solution was stirred at room temperature for 2 hours. Water was then added, 
and the mixture was extracted with CH2Cl2. The combined organic extracts were dried, filtered, and 
concentrated to afford the corresponding cyano derivative, which was used in the next step without 
purification. Second step: AcOH (17 µL) was added to a solution of NaBH3CN (28 mg, 0.45 mmol) in 
CH3CN (120 µL), and the solution was stirred at room temperature for 30 minutes. Then a solution of 
the above cyano compound (88 mg, 0.075 mmol) in CH3CN (115 µL) was added, and the resulting 
mixture was stirred at room temperature for 9 h. CH2Cl2 and 4 N aqueous NaOH were then added, and 
the mixture was extracted with CH2Cl2. The organic extracts were washed with brine, dried, filtered, and 
concentrated. Flash chromatography of the residue (9:1 hexane–EtOAc) afforded compound 17 (35 mg, 
70%, two steps): IR (film) ν (cm-1) 1111 (OSi); 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) δ 1.06 [s, 
9H, C(CH3)3], 1.56 (td, J = 11.6, 4.8 Hz, 1H, H-1), 1.62-1.72 (m, 3H, H-2, H-6), 1.88-1.92 (m, 2H, H-1, 
H-5), 2.11 (t, J = 14.8 Hz, 1H, H-5), 2.22-2.28 (m, 2H, H-6, H-8), 2.48 (brs, 1H, H-2a), 2.70-2.76 (m, 
2H, H-6a, H-9), 2.88 (m, 1H, H-9), 3.40-3.47 (m, 2H, H-8, H-14b), 3.77 (s, 3H, CH3O), 4.11 (s, 2H, 
CH2OSi), 5.18 (d, J = 17.2 Hz, 1H, NCH2), 5.30 (d, J = 17.2 Hz, 1H, NCH2), 5.33 (m, 1H, H-3), 6.80 
(d, J = 8.8 Hz, 2H, ArH), 6.88 (d, J = 8.8 Hz, 2H, ArH), 7.06-7.10 (m, 3H, ArH), 7.29-7.37 (m, 7H, 
ArH), 7.51-7.53 (m, 1H, ArH), 7.48 (m, 1H, ArH), 7.67-7.70 (m, 2H, ArH); 13C NMR (100.6 MHz, 
CDCl3) δ 19.3 [C(CH3)3], 21.3 (C-5), 23.1 (C-9), 26.8 [C(CH3)3], 27.1 (C-6), 28.5 (C-1), 30.2 (C-2), 
36.0 (C-2a), 46.3 (C-8), 47.6 (NCH2), 55.2 (CH3O), 58.6 (C-6a), 59.9 (C-14b), 67.5 (CH2OSi), 109.7 
(CHAr), 114.0 (CHAr), 118.0 (CHAr), 119.2 (CHAr), 121.1 (CHAr), 124.6 (C-3), 127.0 (CHAr), 127.1 
(CHAr), 127.5 (CHAr), 129.0 (CAr), 129.5 (CHAr), 129.5 (CHAr), 129.9 (CAr), 133.9 (CAr), 134.0 
(CAr), 135.4 (CHAr), 135.5 (CHAr), 137.7 (CAr), 137.9 (C-4), 138.1 (CAr), 158.6 (CAr); HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C44H51N2O2Si 667.3714; Found 667.3711. 
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(2aR,6aS,14bS)-4-(Hydroxymethyl)-2,2a,5,6,6a,8,9,14b-octahydro-1H-benz[f]indolo[2,3-a]-
quinolizine (5): First step: Thiophenol (125 µl, 2.25 mmol) and cold TFA (1.40 mL) were added at 0 
°C to compound 17 (30 mg, 0.045 mmol), and the mixture was stirred for 2 h. The solution was poured 
into a cold saturated solution of NaHCO3, and the resulting mixture was extracted with CH2Cl2. The 
combined organic extracts were dried, filtered, and concentrated. Flash chromatography (4:1 hexane–
EtOAc) afforded the deprotected indole derivative (22 mg, 90%): 1H NMR (400 MHz, CDCl3, COSY, 
g-HSQC) δ 1.01 [s, 9H, C(CH3)3], 1.57-1.69 (m, 2H, H-1), 1.82 (m, 3H, H-2, H-5, H-6), 2.05 (m, 1H, 
H-5), 2.28 (m, 2H, H-6, H-8), 2.55 (brs, 1H, H-2a), 2.65 (brs, 1H, H-6a), 2.70 (d, J = 15.2 Hz, 1H, H-9), 
2.82 (m, 1H, H-9), 3.35 (brd, J = 10.4 Hz, 1H, H-14b), 3.47 (dd, J = 11.2, 4.0 Hz, 1H, H-8), 4.02 (d, J = 
13.2 Hz, 1H, CH2OSi), 4.09 (d, J = 13.2 Hz, 1H, CH2OSi), 5.38 (m, 1H, H-3), 7.07-7.20 (m, 6H, ArH), 
7.27-7.32 (m, 4H, ArH), 7.62-7.67 (m, 4H, ArH), 7.69 (brs, 1H, NH); 13C NMR (100.6 MHz, CDCl3) 
δ 19.3 [C(CH3)3], 20.8 (C-5), 22.6 (C-9), 26.8 [C(CH3)3], 26.9 and 27.1 (C-6, C-1), 30.1 (C-2), 36.3 (C-
2a), 47.4 (C-8), 58.0 (C-6a), 59.8 (C-14b), 67.3 (CH2OSi), 108.7 (CAr), 110.7 (CHAr), 118.0 (CHAr), 
119.3 (CHAr), 121.1 (CHAr), 123.9 (C-3), 127.4 (CHAr), 127.5 (CHAr), 129.4 (CHAr), 129.5 (CHAr), 
133.8 (CAr), 134.0 (CAr), 135.4 (CHAr), 135.5 (CHAr), 136.0 (CAr), 137.9 (C-4). Second step: TBAF 
(55 µl, 0.055 mmol) was added at 0 °C to a solution of the above deprotected indole derivative (15 mg, 
0.028 mmol) in THF (2.8 mL). The mixture was stirred for 4 h, and then concentrated under reduced 
pressure. Flash chromatography of the residue afforded pentacyclic alcohol 5 (7 mg, 85%): mp: 241-242 
ºC; 1H NMR (500 MHz, CD3OD, g-HSQC) δ 1.33 (m, 1H, H-1), 1.56-1.64 (m, 1H, H-2), 1.72 (td, J = 
14.0, 6.0 Hz, 1H, H-6), 1.86-1.96 (m, 2H, H-1, H-5), 2.16-2.22 (m, 2H, H-2, H-5), 2.40 (dm, J = 14.0 
Hz, 1H, H-6), 2.46 (m, 1H, H-8), 2.62 (brs, 1H, H-2a), 2.77 (dd, J = 16.0, 4.0 Hz, 1H, H-9), 2.82 (brs, 
1H, H-6a), 2.93 (dm, J = 16.0 Hz, 1H, H-9), 3.56 (brs, 1H, H-14b), 3.68 (m, 1H, H-8), 3.92 (s, 2H, 
CH2OH), 5.39 (brs, 1H, H-3), 6.95 (td, J = 8.0, 1.5 Hz, 1H, ArH), 7.03 (td, J = 8.0, 1.5 Hz, 1H, ArH), 
7.27 (d, J = 7.5 Hz, 1H, ArH), 7.37 (d, J = 7.5 Hz, 1H, ArH); when the spectrum was recorded in 
CF3CO2D (400 MHz), the olefinic proton appeared at δ 5.86 as a broad singlet; 13C NMR (125.0 MHz, 
CD3OD) δ 22.1 (C-5), 22.5 (C-9), 26.9 and 27.3 (C-2, C-6), 30.7 (C-1), 37.3 (C-2a), 48.8 (C-8), 60.8 (C-
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6a), 62.4 (C-14b), 67.7 (CH2OH), 108.2 (CAr), 111.9 (CHAr), 118.6 (CHAr), 119.8 (CHAr), 122.0 
(CHAr), 127.2 (C-3), 128.3 (CAr), 136.0 (CAr), 138.1 (CAr), 139.9 (C-4); m/z (%) 308 (91, M+), 307 
(100, [M-1]+), 291 (44), 277 (17), 223 (15), 197 (24), 184 (36), 171 (29), 170 (58), 169 (68), 156 (21), 
144 (31); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C20H25N2O 309.1961; Found 309.1954. 
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